Spirendolol

Spirendolol
Names
	IUPAC name 4-[3-(tert-Butylamino)-2-hydroxypropoxy]spiro[3H-indene-2,1'-cyclohexane]-1-one
Identifiers
CAS Number	65429-87-0 ;
3D model (JSmol)	Interactive image;
ChemSpider	62090;
PubChem CID	68857;
UNII	96789094BR ;
	InChI InChI=1S/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3 Key: YLBMSIZZTJEEIO-UHFFFAOYSA-N; InChI=1/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3 Key: YLBMSIZZTJEEIO-UHFFFAOYAB;
	SMILES CC(C)(C)NCC(COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O;
Properties
Chemical formula	C21H31NO3
Molar mass	345.483 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Spirendolol is a beta adrenergic receptor antagonist.^[1]

References

^ Mostaghim, R; Maddox, YT; Ramwell, PW (1986). "Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents". The Journal of Pharmacology and Experimental Therapeutics. 239 (3): 797–801. PMID 2879033.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.